Back
  1. Home
  2. Profile of Valérie Bleret (ULiège)
Profil

Bleret Valérie

Département des sciences cliniques

See author's contact details
Main Referenced Co-authors
Lifrange, Eric  (12)
Desreux, Joëlle  (8)
Herman, Philippe  (5)
Van Cauwenberge, Jean-Rémy  (5)
Coucke, Philippe  (3)
Main Referenced Keywords
Female (6); Humans (6); Breast cancer (3); breast cancer (2); breast neoplasm (2);
Main Referenced Disciplines
Oncology (8)
Radiology, nuclear medicine & imaging (5)
Endocrinology, metabolism & nutrition (3)
Reproductive medicine (gynecology, andrology, obstetrics) (3)
Orthopedics, rehabilitation & sports medicine (2)

Publications (total 16)

The most downloaded
1374 downloads
BLERET, V., PINTIAUX, A., BELIARD, A., Kridelka, F., LIFRANGE, E., Van Cauwenberge, J.-R., & DESREUX, J. (2011). Prise en charge des consequences de la carence oestrogenique apres cancer du sein. Revue Médicale de Liège, 66 (5-6), 385-92. https://hdl.handle.net/2268/114778

The most cited

18 citations (OpenAlex)

Mlakar, I., Lin, S., Aleksandraviča, I., Arcimoviča, K., Eglītis, J., Leja, M., Salgado Barreira, Á., Gómez, J. G., Salgado, M., Mata, J. G., Batorek, D., Horvat, M., Molan, M., Ravnik, M., Kaux, J.-F., BLERET, V., LOLY, C., Maquet, D., Sartini, E., & Smrke, U. (August 2021). Patients-centered SurvivorShIp care plan after Cancer treatments based on Big Data and Artificial Intelligence technologies (PERSIST): a multicenter study protocol to evaluate efficacy of digital tools supporting cancer survivors. BMC Medical Informatics and Decision Making, 21 (1), 243. doi:10.1186/s12911-021-01603-w https://hdl.handle.net/2268/263937

Arioz, U., Mlakar, I., Smrke, U., Šafran, V., Lin, S., Nateqi, J., Bema, D., Polaka, I., Arcimovica, K., Lescinska, A. M., Manzo, G., Calbimonte, J.-P., Calvo-Almeida, S., Ravnik, M., Horvat, M., Montero, A. M., Cruz, B. C., Arjona, J. A., Chavez, M., ... Flis, V. (2024). Improving Self-Efficacy and Patient Activation in Cancer Survivors through Digital Health Interventions: Findings from the PERSIST Project (Preprint). Journal of Medical Internet Research. doi:10.2196/preprints.57575

Manzo, G., Pannatier, Y., Duflot, P., Kolh, P., Chavez, M., Bleret, V., Calvaresi, D., Jimenez-Del-Toro, O., Schumacher, M., & Calbimonte, J.-P. (25 January 2023). Breast cancer survival analysis agents for clinical decision support. Computer Methods and Programs in Biomedicine, 231, 107373. doi:10.1016/j.cmpb.2023.107373
Peer Reviewed verified by ORBi

Mlakar, I., Lin, S., Nateqi, J., Gruarin, S., Diéguez, L., Piairo, P., Pires, L. R., Tement, S., Aleksandraviča, I., Leja, M., Arcimoviča, K., BLERET, V., KAUX, J.-F., Kolh, P., MAQUET, D., Gómez, J. G., Mata, J. G., Salgado, M., Horvat, M., ... Smrke, U. (April 2022). Establishing an Expert Consensus on Key Indicators of the Quality of Life among Breast Cancer Survivors: A Modified Delphi Study. Journal of Clinical Medicine, 11 (7), 2041. doi:10.3390/jcm11072041
Peer Reviewed verified by ORBi

Mlakar, I., Lin, S., Aleksandraviča, I., Arcimoviča, K., Eglītis, J., Leja, M., Salgado Barreira, Á., Gómez, J. G., Salgado, M., Mata, J. G., Batorek, D., Horvat, M., Molan, M., Ravnik, M., Kaux, J.-F., BLERET, V., LOLY, C., Maquet, D., Sartini, E., & Smrke, U. (August 2021). Patients-centered SurvivorShIp care plan after Cancer treatments based on Big Data and Artificial Intelligence technologies (PERSIST): a multicenter study protocol to evaluate efficacy of digital tools supporting cancer survivors. BMC Medical Informatics and Decision Making, 21 (1), 243. doi:10.1186/s12911-021-01603-w
Peer Reviewed verified by ORBi

Bleret, V., Cusumano, P., Danthine, D., Desreux, J., HOUET, E., REMACLE, N., & Lifrange, E. (May 2021). Cancer du sein : évaluation individualisée du risque en vue d’un dépistage sur mesure. Revue Médicale de Liège, 76 (5-6), 502 - 506.
Editorial Reviewed verified by ORBi

DESREUX, J., BLERET, V., & LIFRANGE, E. (2012). Should we individualize breast cancer screening? Maturitas, 73, 202-205. doi:10.1016/j.maturitas.2012.08.004
Peer Reviewed verified by ORBi

BLERET, V., Cusumano, P., DEZFOULIAN, B., NARDELLA, D., Nizet, J.-L., Van Cauwenberge, J.-R., & LIFRANGE, E. (2011). Mastectomie bilaterale prophylactique chez les patientes a tres haut risque de cancer mammaire: au-dela de la technique. Revue Médicale de Liège, 66 (5-6), 250-3.
Peer reviewed

LIFRANGE, E., ANDRE, C., BLERET, V., COLLIGNON, J., COUCKE, P., CUSUMANO, G., DESREUX, J., HERMAN, P., JERUSALEM, G., KRIDELKA, F., MARTIN, M., RORIVE, A., Van Cauwenberge, J.-R., & COLIN, C. (2011). Hormonothérapie du cancer du sein. Revue Médicale de Liège, 66 (5-6), 367-371.
Peer reviewed

BLERET, V., DESREUX, J., Cusumano, P., HERMAN, P., Kridelka, F., REMACLE, N., THILLE, A., & LIFRANGE, E. (2011). Prevention primaire et secondaire chez les femmes a haut risque de cancer mammaire. Revue Médicale de Liège, 66 (5-6), 245-9.
Peer reviewed

LIFRANGE, E., ANDRE, C., BLERET, V., BRADFER, J., CRISTINELLI, S., COUCKE, P., CUSUMANO, G., FRIDMAN, V., JERUSALEM, G., MARION, F., & COLIN, C. (2011). Prise en charge et suivi d'une série consécutive de 411 patientes opérées pour cancer du sein. Revue Médicale de Liège, 66 (5-6), 329-335.
Peer reviewed

BLERET, V., PINTIAUX, A., BELIARD, A., Kridelka, F., LIFRANGE, E., Van Cauwenberge, J.-R., & DESREUX, J. (2011). Prise en charge des consequences de la carence oestrogenique apres cancer du sein. Revue Médicale de Liège, 66 (5-6), 385-92.
Peer reviewed

Cusumano, P., BLERET, V., Nos, C., Hustinx, R., LILET, H., Gomez, P., & LIFRANGE, E. (2011). Ganglion sentinelle et sentibras: pour un "staging" axillaire sur mesure. Revue Médicale de Liège, 66 (5-6), 336-40.
Peer reviewed

DESREUX, J., Gaspard, U., BLERET, V., Van Cauwenberge, J.-R., THILLE, A., HERMAN, P., & LIFRANGE, E. (2011). Le cancer du sein en Belgique: pourquoi sommes-nous les premiers en Europe? Revue Médicale de Liège, 66 (5-6), 231-7.
Peer reviewed

Bleret, V., Collignon, J., Coucke, P., Cusumano, G., DESREUX, J., Herman, P., Jerusalem, G., Maweja, S., Remacle, N., Rorive, A., & Lifrange, E. (2010). L'observance au traitement de longue durée : le cas particulier de l'hormonothérapie adjuvante du cancer du sein. Revue Médicale de Liège, 65 (5-6), 405-408.
Peer reviewed

Bleret, V., Lifrange, E., Ghuysen, V., Milet, J., Fridman, V., & Colin, C. (January 2008). Validation de la technique de biopsie du ganglion sentinelle dans le cancer du sein. Revue Médicale de Liège, 63 (1), 37-42.
Peer reviewed

Lifrange, E., Bleret, V., Desreux, J., Dondelinger, R., Foidart, J.-M., Gaspard, U., Herman, P., Van Cauwenberge, J.-R., & Colin, C. (May 2003). Interet et limites du depistage de masse du cancer du sein par mammographie seule (mammotest). Revue Médicale de Liège, 58 (5), 331-7.
Peer reviewed

Contact ORBi